Biotech and Pharma
Kantify’s expertise in applying AI and machine learning to biotech and pharma
How the biotech and pharma sectors are being transformed by AI
The drug discovery process is long, uncertain and costly. Kantify helps pharma and biotech companies significantly accelerate and reduce their clinical failure rate.
How Kantify helps pharma and biotech companies
Small molecule discovery
Kantify has developed ZeptoNet, a software solution based on deep learning (a subset of Machine Learning). ZeptoNet is able to predict whether or not a drug candidate shows a certain type of bioactivity (e.g. inhibition or activation) on a protein.
Has a high accuracy (superior to the state of the art)
Makes use of more than 100 bioassays (to date)
And can run in a very limited amount of time.
Read more in our White Paper.
Tailored projects in drug discovery and development
On top of its work on small molecule discovery, Kantify helps biotech and pharma companies with specific challenges to develop predictions and analytics that are tailored to their needs, whether it is a Proof of Concept or the development of a tailored AI model.
Are you looking to develop or assess a potential AI solution in the field of biotech and pharma? Contact us here to have a conversation with our team of experts. You can also find more about our expertise by checking our use cases in biotech and pharma below. If your use case is not present, just get in touch with us, we will provide you with a first feasibility assessment.